Francisco López-Medrano Selected Research

Pulmonary Hypertension

11/2021	Complications associated with peripherally inserted central catheters and Hickman™ in patients with advanced pulmonary hypertension treated with intravenous prostanoids.
12/2012	High incidence of bloodstream infection due to gram-negative bacilli in patients with pulmonary hypertension receiving intravenous treprostinil.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francisco López-Medrano Research Topics

Disease

53	Infections 02/2024 - 03/2003
19	COVID-19 02/2024 - 07/2020
11	Sepsis (Septicemia) 10/2023 - 12/2012
11	Human Influenza (Influenza) 01/2020 - 01/2006
10	Pneumonia (Pneumonitis) 02/2024 - 05/2005
6	Fever (Fevers) 10/2023 - 05/2010
5	Urinary Tract Infections (Urinary Tract Infection) 01/2023 - 02/2018
5	Leishmaniasis 01/2022 - 08/2010
4	Cytomegalovirus Infections (Inclusion Disease) 02/2024 - 10/2009
4	Viremia 02/2024 - 08/2021
4	Bacteriuria 01/2023 - 10/2010
4	Neoplasms (Cancer) 10/2022 - 03/2013
4	Endocarditis 01/2022 - 01/2009
4	Bacteremia 06/2021 - 11/2009
3	Clostridium Infections 12/2023 - 08/2015
3	Cross Infection (Nosocomial Infection) 12/2023 - 04/2005
3	Diabetes Mellitus 10/2022 - 10/2009
3	Chronic Obstructive Pulmonary Disease (COPD) 09/2022 - 05/2005
3	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 01/2006
3	Communicable Diseases (Infectious Diseases) 01/2019 - 08/2011
3	Bacterial Infections (Bacterial Infection) 12/2018 - 08/2011
3	Opportunistic Infections (Opportunistic Infection) 12/2018 - 07/2014
3	Visceral Leishmaniasis (Kala Azar) 02/2017 - 01/2015
2	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 09/2012
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 01/2009
2	Septic Shock (Toxic Shock Syndrome) 10/2022 - 01/2022
2	Tuberculosis (Tuberculoses) 09/2022 - 09/2008
2	Invasive Candidiasis 05/2022 - 01/2018
2	Hypersensitivity (Allergy) 01/2022 - 08/2012
2	Aspergillosis 11/2021 - 01/2021
2	Pulmonary Hypertension 11/2021 - 12/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 06/2021 - 01/2018
2	Cytokine Release Syndrome 04/2021 - 04/2021
2	Persistent Infection 02/2017 - 12/2010
2	Agammaglobulinemia (Hypogammaglobulinemia) 01/2017 - 08/2015
2	Pleural Effusion (Pleural Effusions) 08/2015 - 05/2005
2	Pulmonary Arterial Hypertension 05/2013 - 12/2012
2	Hepatitis 08/2012 - 01/2008
2	Glomerulonephritis 03/2011 - 10/2010
2	Proteinuria 03/2011 - 10/2010
1	Abdominal Pain (Pain, Abdominal) 06/2023
1	Endometritis 06/2023
1	Multiple Myeloma 01/2023
1	Pyogenic Liver Abscess 01/2023
1	Disease Progression 01/2023
1	Hematologic Diseases (Blood Diseases) 10/2022

Drug/Important Bio-Agent (IBA)

13	Anti-Bacterial Agents (Antibiotics)IBA 10/2022 - 04/2005
9	tocilizumab (atlizumab)FDA Link 06/2022 - 11/2020
8	Biomarkers (Surrogate Marker)IBA 12/2023 - 03/2013
5	Antiviral Agents (Antivirals)IBA 02/2024 - 01/2012
5	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2022 - 03/2003
5	CytokinesIBA 01/2022 - 01/2015
4	Immunoglobulin G (IgG)IBA 01/2022 - 08/2015
4	CreatinineIBA 05/2013 - 09/2008
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2023 - 03/2011
3	AntibodiesIBA 09/2023 - 01/2018
3	Valganciclovir FDA Link 09/2023 - 01/2008
3	Fosfomycin FDA Link 01/2023 - 04/2015
3	Ganciclovir (Cytovene)FDA LinkGeneric 08/2021 - 01/2004
3	C-Reactive ProteinIBA 06/2021 - 12/2010
3	VaccinesIBA 01/2020 - 07/2010
3	FluoroquinolonesIBA 01/2018 - 05/2005
3	Vancomycin FDA LinkGeneric 01/2017 - 12/2010
3	Oseltamivir (Tamiflu)FDA Link 10/2012 - 09/2011
2	carbapenemaseIBA 12/2023 - 06/2022
2	AntigensIBA 01/2022 - 12/2021
2	Oxygen (Dioxygen)IBA 01/2022 - 06/2020
2	Moxifloxacin (Avelox)FDA Link 01/2021 - 12/2010
2	InterferonsIBA 01/2021 - 01/2021
2	Methicillin (Metin)FDA Link 11/2018 - 01/2016
2	polyglucosanIBA 01/2018 - 01/2018
2	miltefosine (Impavido)IBA 02/2017 - 08/2013
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 05/2013 - 12/2012
2	Clopidogrel (Plavix)FDA Link 08/2012 - 03/2007
2	QuinolonesIBA 12/2010 - 05/2005
1	remdesivirIBA 02/2024
1	MicroRNAs (MicroRNA)IBA 02/2024
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2023
1	LactoferrinIBA 12/2023
1	LipidsIBA 10/2023
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 09/2023
1	nirmatrelvir and ritonavir drug combinationIBA 01/2023
1	cyclo(Arg-Pro) (CI 4)IBA 10/2022

Therapy/Procedure

26	Therapeutics 10/2023 - 03/2003
23	Kidney Transplantation 02/2024 - 09/2008
17	Transplantation 02/2024 - 10/2009
11	Catheters 06/2022 - 11/2009
10	Organ Transplantation 10/2022 - 09/2012
6	Liver Transplantation 01/2023 - 01/2004
5	Immunomodulation 06/2022 - 03/2011
3	Salvage Therapy 01/2023 - 02/2017
3	Length of Stay 10/2012 - 09/2011
3	Artificial Respiration (Mechanical Ventilation) 10/2012 - 09/2011
2	Drug Therapy (Chemotherapy) 01/2023 - 06/2010
2	Duration of Therapy 08/2021 - 11/2020
2	Radiotherapy 04/2021 - 01/2009
2	Heart Transplantation (Grafting, Heart) 12/2020 - 08/2015
1	Renal Replacement Therapy (Therapies, Renal Replacement) 10/2023
1	Curettage 06/2023
1	Hematopoietic Stem Cell Transplantation 01/2023